CClinicalTrials.gg
Active, not recruitingNCT07026409Updated Jun 18, 2025

This Study Will Assess the Etiology, Potential Risk Factors, and Seizure Types in Patients Over 50 With Epileptic Seizure Disorder, Using Laboratory Tests, EEG, and Neuroimaging Findings.

An observational study in Epilepsy, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.

Sponsored by Sohag University · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
50 Years and older
Sex
All
01

Study summary

This study underscores the importance of studying the etiology, clinical characteristics, and types of epilepsy in the elderly to improve diagnosis and management in our community.

02

Conditions studied

  • Epilepsy

Keywords

  • Epilepsy,Elderly,Seizure,EEG.
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's planned enrollment of 100 is close to the median of 102 across 521 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This study will include all consecutive patients aged 50 years and older who are admitted to the inpatient Neuropsychiatry Department or attend the Epilepsy Specialized Outpatient Clinic at Sohag University Hospital with epilepsy or new-onset epileptic .

Inclusion criteria

  • The diagnosis of epilepsy and epileptic seizures will be clinically established based on patient history, following the Glossary of Descriptive Terminology for Ictal Semiology by the International League Against Epilepsy (ILAE) Task Force on Classification and Terminology, as well as the Operational Classification of Seizure Types (ILAE, 2017).

Exclusion criteria

Exclusion Criteria:

    • Inability to determine the onset of epilepsy or epileptic seizures, or a history of seizures occurring before the age of 50.

      • Metabolic disturbances such as hypoglycemia, uremia, or electrolyte imbalances.
      • Patients who refuse to participate in the study.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Risk factors of epilepsy in elderly

    MRI brain for structural or pathological abnormalities

    Time frame: Baseline

  2. Etiology of epilepsy in elderly

    Electroencephalography for electrical changes.

    Time frame: Baseline

07

Study locations

1 site
  • Faculty of Medicine Sohag University
    Sohag, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07026409
Lead sponsor
Sohag University
Responsible party
Mostafa Elsayed Abdelwahab (Resident at Department of Neurology and Psychological Medicine Sohag university hospital., Sohag University) — Principal investigator
First posted
Jun 18, 2025
Start date
Mar 1, 2025
Primary completion
Oct 2025 (estimated)
Completion
Oct 1, 2025 (estimated)
Last update
Jun 18, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion